DKK1 and cancer: Interestingly, latent competent cancer cells expressing SOX2/SOX9 increase dormant CSCs (or latency-competent cancer cells) that downregulate NKG2DL through a unique mechanism that produces the WNT inhibitor DKK1, thus evading NK cell-mediated immunity57.